Lobbying disclosures · Lobbying report
NTRA: second_quarter 2026 lobbying report
Coverage and reimbursement for innovative lab-developed tests.
Follow NTRA- Became public
- Jun 18, 2026, 3:01 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 9, 2026, 1:48 PM EST
Why this is connected
Exact legal-name match: Natera, Inc. (https://www.sec.gov/Archives/edgar/data/1604821/).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/29453b1e-ff4b-40cf-aeb6-1b14c2f3f7ee/","filing_uuid":"29453b1e-ff4b-40cf-aeb6-1b14c2f3f7ee","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/29453b1e-ff4b-40cf-aeb6-1b14c2f3f7ee/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2026-06-18T15:01:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2231 48th Street NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":401108183,"url":"https://lda.gov/api/v1/registrants/401108183/","house_registrant_id":56368,"name":"LMH STRATEGIC SOLUTIONS","description":null,"address_1":"2231 48th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20007","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALANNA TEMME","contact_telephone":"+1 202-503-5189","dt_updated":"2026-07-09T12:14:41.865548-04:00"},"client":{"id":73614,"url":"https://lda.gov/api/v1/clients/73614/","client_id":73614,"name":"NATERA, INC.","general_description":"Health care testing and diagnostics company.","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-06-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Coverage and reimbursement for innovative lab-developed tests.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":149520,"prefix":null,"prefix_display":null,"first_name":"SONIA","nickname":null,"middle_name":null,"last_name":"GOH","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153409,"prefix":null,"prefix_display":null,"first_name":"SOPHIE","nickname":null,"middle_name":null,"last_name":"KHANAHMADI","suffix":null,"suffix_display":null},"covered_position":"Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions","new":true},{"lobbyist":{"id":153410,"prefix":null,"prefix_display":null,"first_name":"MAXIMILIAN","nickname":null,"middle_name":null,"last_name":"WALTER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":145804,"prefix":null,"prefix_display":null,"first_name":"ALANNA","nickname":null,"middle_name":null,"last_name":"TEMME","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, U.S. Representative Jon Porter","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Price change after we could observe it
+2.51% NTRA
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in NTRA
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 15, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Sep 22, 2025 · disclosed Oct 15, 2025 · Joint
- Sep 5, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Aug 22, 2025 · disclosed Sep 5, 2025 · Joint
- Aug 11, 2025$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 11, 2025 · Joint
- Dec 5, 2024$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded Nov 20, 2024 · disclosed Dec 5, 2024 · Joint
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- May 4, 2021$1K–$15K
Sen. Bill Hagerty (R-TN)
$1K–$15K · Traded Apr 20, 2021 · disclosed May 4, 2021
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.